Huakun Lv

1.2k total citations
61 papers, 782 citations indexed

About

Huakun Lv is a scholar working on Infectious Diseases, Epidemiology and Health. According to data from OpenAlex, Huakun Lv has authored 61 papers receiving a total of 782 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Infectious Diseases, 29 papers in Epidemiology and 13 papers in Health. Recurrent topics in Huakun Lv's work include Influenza Virus Research Studies (15 papers), Vaccine Coverage and Hesitancy (13 papers) and Viral gastroenteritis research and epidemiology (12 papers). Huakun Lv is often cited by papers focused on Influenza Virus Research Studies (15 papers), Vaccine Coverage and Hesitancy (13 papers) and Viral gastroenteritis research and epidemiology (12 papers). Huakun Lv collaborates with scholars based in China, United States and Taiwan. Huakun Lv's co-authors include Jimin Sun, Chengliang Chai, Shelan Liu, Junfen Lin, Said Amer, Chengmin Wang, Hongxuan He, Jianmin Jiang, Zhenyu Gong and Enfu Chen and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Huakun Lv

56 papers receiving 764 citations

Peers

Countries citing papers authored by Huakun Lv

Since Specialization

Citations

This map shows the geographic impact of Huakun Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huakun Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huakun Lv more than expected).

Fields of papers citing papers by Huakun Lv

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huakun Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huakun Lv. The network helps show where Huakun Lv may publish in the future.

Co-authorship network of co-authors of Huakun Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Huakun Lv. A scholar is included among the top collaborators of Huakun Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huakun Lv. Huakun Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Scenario-based simulation of ecosystem service supply and demand in China's Yangtze River Economic Belt 2025 ·Environmental Research ·(unknown), Fei Feng, (unknown), (unknown), (unknown), (unknown), Huakun Lv, (unknown), Giovanni Sanesi, Raffaele Lafortezza	0
2	Efficacy and safety of a China-developed live attenuated herpes zoster vaccine in Chinese healthy adults aged 40 years and older: a multicentre, randomized, double-blind, placebo-controlled, phase 3 clinical trial 2025 ·Clinical Microbiology and Infection ·Shenyu Wang, (unknown), Yaru Quan, Huakun Lv, (unknown), Xiao Hu, Qi Liang, Ying-ping Chen, Mingwei Wei, Qiang Lü, (unknown), Zhenzhen Liang, (unknown), Na Xu, Zhiping Chen	0
3	Vaccination coverage by age 24 months among children born in 2020 and 2021 in China, during the COVID-19 pandemic: A study based on the national immunization information system 2025 ·Vaccine ·Wenqi Huang, Miao Xu, (unknown), Jing Chen, Huakun Lv, Jianqiao Li, (unknown), Hui Liang, Dong Wang, Fangfang Zeng, Dan Liu, Fengrui Jing, Xiaofeng Liang	0
4	Evaluation of antibody kinetics and durability in healthy individuals vaccinated with inactivated COVID-19 vaccine (CoronaVac): A cross-sectional and cohort study in Zhejiang, China 2023 ·eLife ·Hangjie Zhang, (unknown), (unknown), Xinpei Zhang, Bo Chen, (unknown), (unknown), Zhongbing Chen, (unknown), (unknown), Shenyu Wang, (unknown), (unknown), Yuting Liao, Juan Yang, Jianmin Jiang, Huakun Lv	6
5	Safety and immunogenicity of Ad5-nCoV immunization after three-dose priming with inactivated SARS-CoV-2 vaccine in Chinese adults 2023 ·Nature Communications ·Hangjie Zhang, (unknown), Yu Xu, Qin Pan, (unknown), (unknown), Shenyu Wang, (unknown), (unknown), Shupeng Zhang, (unknown), Yuting Liao, Juan Yang, Xiaowei Hu, Jianmin Jiang, Huakun Lv	9
6	Safety and immunogenicity of heterologous recombinant protein subunit vaccine (ZF2001) booster against COVID-19 at 3–9-month intervals following two-dose inactivated vaccine (CoronaVac) 2022 ·Frontiers in Immunology ·Yuting Liao, Ying-ping Chen, Bo Chen, (unknown), Xiao Hu, Bo Xing, Juan Yang, (unknown), (unknown), (unknown), Huakun Lv	8
7	Knowledge, attitudes, and practices toward COVID-19: A cross-sectional study during normal management of the epidemic in China 2022 ·Frontiers in Public Health ·Juan Yang, Yuting Liao, (unknown), (unknown), Huakun Lv	5
8	Immunogenicity and safety of the 9-valent human papillomavirus vaccine in Chinese females 9–45 years of age: A phase 3 open-label study 2022 ·Vaccine ·Huakun Lv, Shenyu Wang, Zhenzhen Liang, Wei Yu, (unknown), Ying-ping Chen, Xiao Hu, Rong Fu, Minghuan Zheng, (unknown), Alain Luxembourg, Xueyan Liao, Zhiping Chen	10
9	Serological and molecular epidemiology of Japanese Encephalitis in Zhejiang, China, 2015-2018 2020 ·PLoS neglected tropical diseases ·(unknown), (unknown), Hanqing He, Rui Yan, Yi Sun, Xuewen Tang, Yang Zhou, Junhang Pan, Haiyan Mao, Yanjun Zhang, Huakun Lv	17
10	Immunogenicity and safety of an accelerated hepatitis E vaccination schedule in healthy adults: a randomized, controlled, open-label, phase IV trial 2019 ·Clinical Microbiology and Infection ·(unknown), Sheng‐Hsiang Lin, (unknown), Yan Luo, Shenyu Wang, (unknown), (unknown), Ting Wu, Shengyu Huang, (unknown), Huakun Lv	16
11	The association of serum markers of fibrosis and development of liver cirrhosis in chronic hepatitis B patients: A systematic review and meta-analysis 2019 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), Jun Yao, Zhengting Wang, Zhifang Wang, (unknown), Huakun Lv, Li Li, Biao Zhou	2
12	Safety and immunogenicity of hepatitis E vaccine in elderly people older than 65 years 2019 ·Vaccine ·(unknown), Zhiping Chen, Shenyu Wang, Huirong Pan, Zhifang Wang, (unknown), Lingzhi Shen, Xiaoping Zheng, (unknown), (unknown), Qing Chen, Ya Zheng, Jun Zhang, Huakun Lv, Shoujie Huang	24
13	Changing Epidemiological Characteristics of Hepatitis A in Zhejiang Province, China: Increased Susceptibility in Adults 2016 ·PLoS ONE ·(unknown), Yaping Chen, Shuyun Xie, Huakun Lv	19
14	Antibodies against Severe Fever with Thrombocytopenia Syndrome Virus in Healthy Persons, China, 2013 2014 ·Emerging infectious diseases ·Lei Zhang, Jimin Sun, (unknown), Huakun Lv, Chengliang Chai, Yi Sun, (unknown), Jianmin Jiang, Zhiping Chen, Jeroen Kortekaas, Yanjun Zhang	21
15	Comparison of Characteristics between Patients with H7N9 Living in Rural and Urban Areas of Zhejiang Province, China: A Preliminary Report 2014 ·PLoS ONE ·Jimin Sun, Zhenyu Gong, Huakun Lv, Zhiping Chen, Chengliang Chai, Shelan Liu, Feng Ling, Lu Ye, Jian‐Piao Cai, Zhao Yu, Ziping Miao, (unknown), Enfu Chen	11
16	Seroprevalence of severe fever with thrombocytopenia syndrome virus in southeastern China and analysis of risk factors 2014 ·Epidemiology and Infection ·Jimin Sun, (unknown), Zhenyu Gong, Linyi Zhang, Huakun Lv, Junfen Lin, Chengliang Chai, (unknown), (unknown), (unknown), (unknown), Xuyang Zheng, (unknown), Fan Ding, Wei‐Chiao Huang, Jianguo Xu, (unknown), Jianmin Jiang	25
17	Novel and Predominant Pathogen Responsible for the Enterovirus-Associated Encephalitis in Eastern China 2013 ·PLoS ONE ·Lei Zhang, Jie Yan, David M. Ojcius, Huakun Lv, Ziping Miao, Yin Chen, Yanjun Zhang, (unknown), (unknown)	24
18	The first avian influenza A (H7N9) viral infection in humans in Zhejiang Province, China: a death report 2013 ·Frontiers of Medicine ·Enfu Chen, Fenjuan Wang, Huakun Lv, Yanjun Zhang, Hua Ding, Shelan Liu, Jian‐Piao Cai, Li Xie, (unknown), Chengliang Chai, Haiyan Mao, Jimin Sun, Junfen Lin, Zhao Yu, Lianhong Li, Zhiping Chen, Shichang Xia	18
19	The effects of booster vaccination on hepatitis B vaccine in anti-HBs negative infants of HBsAg-positive mothers after primary vaccination 2013 ·Human Vaccines & Immunotherapeutics ·Hua Gu, Jun Yao, Wei Zhu, Huakun Lv, (unknown), (unknown), Shichang Xia, (unknown)	4
20	Inapparent Infection During an Outbreak of Dengue Fever in Southeastern China 2012 ·Viral Immunology ·Jimin Sun, Shuying Luo, (unknown), Jinhua Chen, Juan Hou, Tao Fu, Huakun Lv, Zhiping Chen, (unknown), Ling Feng, Chengliang Chai, Yanjun Zhang, Haiyan Mao, Ju-ying Yan, Yi-yu Lu, Qiyong Liu, Xiuping Song, Liang Lu	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact